Events

DG R&I webinar “A successful proposal for Horizon Europe: Scientific-technical excellence is key, but don’t forget the other aspects”
APR
Wed
21
10:00 - 12:30

This was 4 years ago

Location

virtual

Programmes
Horizon Europe SwafS H2020 L+F

A webinar is organised by the directorate-general for research and innovation, directorate B Common Implementation Centre, of the European Commission on proposal writing, more specifically on the topics outside excellence. The topics that will be presented are impact, open science, gender dimension, dissemination, exploitation and communication and the “do no significant harm” principle.

The webinar is a follow-up of the webinar “How to prepare a successful proposal in Horizon Europe” of 24 March.

Registration page and the agenda can be found here

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.